Stock Events

ALK-Abello AS 

kr130.8
0
+kr0+0% Today

Statistics

Day High
131
Day Low
129.5
52W High
158.7
52W Low
82.4
Volume
4,006
Avg. Volume
62,713
Mkt Cap
27.71B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Mar 17
kr5
Mar 16
kr5
Mar 15
kr5
Mar 14
kr5
Mar 13
kr5

Earnings

9NovConfirmed
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.09
0.19
0.46
0.74
Expected EPS
N/A
Actual EPS
0.23

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0OIR.LSE. It's not an investment recommendation.

About

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.
Show more...
CEO
Mr. Carsten Hellmann
Employees
2587
Country
DK
ISIN
DK0061802139
WKN
000A3DHX9

Listings